Proceedings: Heparinless venoarterial bypass. Its application in the treatment of experimental cardiogenic shock.
D000818:Animals; D001243:Assisted Circulation / Q000295:instrumentation*; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output; D006348:Cardiac Surgical Procedures / Q000295:instrumentation* / Q000401:mortality; D002496:Central Venous Pressure; D003326:Coronary Circulation; D004285:Dogs; D004562:Electrocardiography; D005069:Evaluation Studies as Topic; D006334:Heart Function Tests; D006493:Heparin; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008722:Methods; D010100:Oxygen / Q000097:blood; D011140:Polyurethanes; D011145:Polyvinyls; D012770:Shock, Cardiogenic / Q000401:mortality / Q000628:therapy*; D013927:Thrombosis / Q000517:prevention & control*
D011140:Polyurethanes; D011145:Polyvinyls; D002245:Carbon Dioxide; D006493:Heparin; D010100:Oxygen